minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.1.0 - STU 2.1
minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.1.0 - STU 2.1
This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.1.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions 
| Active as of 2023-03-21 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="elixhauser-neurological-movement-disorder-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/5.0.0/CodeSystem-icd10CM.html"><code>http://hl7.org/fhir/sid/icd-10-cm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>G08</td><td>Intracranial and intraspinal phlebitis and thrombophlebitis</td></tr><tr><td>G10</td><td>Huntington's disease</td></tr><tr><td>G11.0</td><td>Congenital nonprogressive ataxia</td></tr><tr><td>G11.1</td><td>Early-onset cerebellar ataxia</td></tr><tr><td>G11.10</td><td>Early-onset cerebellar ataxia, unspecified</td></tr><tr><td>G11.11</td><td>Friedreich ataxia</td></tr><tr><td>G11.19</td><td>Other early-onset cerebellar ataxia</td></tr><tr><td>G11.2</td><td>Late-onset cerebellar ataxia</td></tr><tr><td>G11.3</td><td>Cerebellar ataxia with defective DNA repair</td></tr><tr><td>G11.4</td><td>Hereditary spastic paraplegia</td></tr><tr><td>G11.8</td><td>Other hereditary ataxias</td></tr><tr><td>G11.9</td><td>Hereditary ataxia, unspecified</td></tr><tr><td>G12.0</td><td>Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]</td></tr><tr><td>G12.1</td><td>Other inherited spinal muscular atrophy</td></tr><tr><td>G12.20</td><td>Motor neuron disease, unspecified</td></tr><tr><td>G12.21</td><td>Amyotrophic lateral sclerosis</td></tr><tr><td>G12.22</td><td>Progressive bulbar palsy</td></tr><tr><td>G12.23</td><td>Primary lateral sclerosis</td></tr><tr><td>G12.24</td><td>Familial motor neuron disease</td></tr><tr><td>G12.25</td><td>Progressive spinal muscle atrophy</td></tr><tr><td>G12.29</td><td>Other motor neuron disease</td></tr><tr><td>G12.8</td><td>Other spinal muscular atrophies and related syndromes</td></tr><tr><td>G12.9</td><td>Spinal muscular atrophy, unspecified</td></tr><tr><td>G13.0</td><td>Paraneoplastic neuromyopathy and neuropathy</td></tr><tr><td>G13.1</td><td>Other systemic atrophy primarily affecting central nervous system in neoplastic disease</td></tr><tr><td>G13.2</td><td>Systemic atrophy primarily affecting the cnsl in myxedema</td></tr><tr><td>G13.8</td><td>Systemic atrophy aff cnsl in oth diseases classd elswhr</td></tr><tr><td>G20</td><td>Parkinson's disease</td></tr><tr><td>G21.0</td><td>Malignant neuroleptic syndrome</td></tr><tr><td>G21.11</td><td>Neuroleptic induced parkinsonism</td></tr><tr><td>G21.19</td><td>Other drug induced secondary parkinsonism</td></tr><tr><td>G21.2</td><td>Secondary parkinsonism due to other external agents</td></tr><tr><td>G21.3</td><td>Postencephalitic parkinsonism</td></tr><tr><td>G21.4</td><td>Vascular parkinsonism</td></tr><tr><td>G21.8</td><td>Other secondary parkinsonism</td></tr><tr><td>G21.9</td><td>Secondary parkinsonism, unspecified</td></tr><tr><td>G23.0</td><td>Hallervorden-Spatz disease</td></tr><tr><td>G23.1</td><td>Progressive supranuclear ophthalmoplegia</td></tr><tr><td>G23.2</td><td>Striatonigral degeneration</td></tr><tr><td>G23.8</td><td>Other specified degenerative diseases of basal ganglia</td></tr><tr><td>G23.9</td><td>Degenerative disease of basal ganglia, unspecified</td></tr><tr><td>G24.09</td><td>Other drug induced dystonia</td></tr><tr><td>G24.1</td><td>Genomic torsion dystonia</td></tr><tr><td>G24.2</td><td>Idiopathic nonfamilial dystonia</td></tr><tr><td>G24.8</td><td>Other dystonia</td></tr><tr><td>G25.4</td><td>Drug-induced chorea</td></tr><tr><td>G25.5</td><td>Other chorea</td></tr><tr><td>G25.70</td><td>Drug induced movement disorder, unspecified</td></tr><tr><td>G25.71</td><td>Drug induced akathisia</td></tr><tr><td>G25.79</td><td>Other drug induced movement disorders</td></tr><tr><td>G25.81</td><td>Restless legs syndrome</td></tr><tr><td>G25.82</td><td>Stiff-man syndrome</td></tr><tr><td>G25.83</td><td>Benign shuddering attacks</td></tr><tr><td>G25.89</td><td>Other specified extrapyramidal and movement disorders</td></tr><tr><td>G25.9</td><td>Extrapyramidal and movement disorder, unspecified</td></tr><tr><td>G26</td><td>Extrapyramidal and movement disord in diseases classd elswhr</td></tr><tr><td>G32.0</td><td>Subac comb degeneration of spinal cord in dis classd elswhr</td></tr><tr><td>G32.81</td><td>Cerebellar ataxia in diseases classified elsewhere</td></tr><tr><td>G32.89</td><td>Oth degeneratv disord of nervous sys in dis classd elswhr</td></tr><tr><td>G80.3</td><td>Athetoid cerebral palsy</td></tr></table></li></ul></div>
</text>
<url
value="http://hl7.org/fhir/us/mcode/ValueSet/elixhauser-neurological-movement-disorder-vs"/>
<version value="2.1.0"/>
<name value="ElixhauserNeurologicalMovementDisorderVS"/>
<title value="Elixhauser Neurological Movement Disorder Value Set"/>
<status value="active"/>
<experimental value="false"/>
<date value="2023-03-21T04:50:14+11:00"/>
<publisher value="HL7 International Clinical Interoperability Council"/>
<contact>
<name value="HL7 International Clinical Interoperability Council"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/cic"/>
</telecom>
<telecom>
<system value="email"/>
<value value="ciclist@lists.HL7.org"/>
</telecom>
</contact>
<description
value="Elixhauser Comorbid Condition Value Set for Neurological Movement Disorders. ICD-10 codes are drawn from https://www.hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comorbidity_icd10.jsp, version 2021.1"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="US"/>
<display value="United States of America"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://hl7.org/fhir/sid/icd-10-cm"/>
<concept>
<code value="G08"/>
<display
value="Intracranial and intraspinal phlebitis and thrombophlebitis"/>
</concept>
<concept>
<code value="G10"/>
<display value="Huntington's disease"/>
</concept>
<concept>
<code value="G11.0"/>
<display value="Congenital nonprogressive ataxia"/>
</concept>
<concept>
<code value="G11.1"/>
<display value="Early-onset cerebellar ataxia"/>
</concept>
<concept>
<code value="G11.10"/>
<display value="Early-onset cerebellar ataxia, unspecified"/>
</concept>
<concept>
<code value="G11.11"/>
<display value="Friedreich ataxia"/>
</concept>
<concept>
<code value="G11.19"/>
<display value="Other early-onset cerebellar ataxia"/>
</concept>
<concept>
<code value="G11.2"/>
<display value="Late-onset cerebellar ataxia"/>
</concept>
<concept>
<code value="G11.3"/>
<display value="Cerebellar ataxia with defective DNA repair"/>
</concept>
<concept>
<code value="G11.4"/>
<display value="Hereditary spastic paraplegia"/>
</concept>
<concept>
<code value="G11.8"/>
<display value="Other hereditary ataxias"/>
</concept>
<concept>
<code value="G11.9"/>
<display value="Hereditary ataxia, unspecified"/>
</concept>
<concept>
<code value="G12.0"/>
<display
value="Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]"/>
</concept>
<concept>
<code value="G12.1"/>
<display value="Other inherited spinal muscular atrophy"/>
</concept>
<concept>
<code value="G12.20"/>
<display value="Motor neuron disease, unspecified"/>
</concept>
<concept>
<code value="G12.21"/>
<display value="Amyotrophic lateral sclerosis"/>
</concept>
<concept>
<code value="G12.22"/>
<display value="Progressive bulbar palsy"/>
</concept>
<concept>
<code value="G12.23"/>
<display value="Primary lateral sclerosis"/>
</concept>
<concept>
<code value="G12.24"/>
<display value="Familial motor neuron disease"/>
</concept>
<concept>
<code value="G12.25"/>
<display value="Progressive spinal muscle atrophy"/>
</concept>
<concept>
<code value="G12.29"/>
<display value="Other motor neuron disease"/>
</concept>
<concept>
<code value="G12.8"/>
<display
value="Other spinal muscular atrophies and related syndromes"/>
</concept>
<concept>
<code value="G12.9"/>
<display value="Spinal muscular atrophy, unspecified"/>
</concept>
<concept>
<code value="G13.0"/>
<display value="Paraneoplastic neuromyopathy and neuropathy"/>
</concept>
<concept>
<code value="G13.1"/>
<display
value="Other systemic atrophy primarily affecting central nervous system in neoplastic disease"/>
</concept>
<concept>
<code value="G13.2"/>
<display
value="Systemic atrophy primarily affecting the cnsl in myxedema"/>
</concept>
<concept>
<code value="G13.8"/>
<display
value="Systemic atrophy aff cnsl in oth diseases classd elswhr"/>
</concept>
<concept>
<code value="G20"/>
<display value="Parkinson's disease"/>
</concept>
<concept>
<code value="G21.0"/>
<display value="Malignant neuroleptic syndrome"/>
</concept>
<concept>
<code value="G21.11"/>
<display value="Neuroleptic induced parkinsonism"/>
</concept>
<concept>
<code value="G21.19"/>
<display value="Other drug induced secondary parkinsonism"/>
</concept>
<concept>
<code value="G21.2"/>
<display value="Secondary parkinsonism due to other external agents"/>
</concept>
<concept>
<code value="G21.3"/>
<display value="Postencephalitic parkinsonism"/>
</concept>
<concept>
<code value="G21.4"/>
<display value="Vascular parkinsonism"/>
</concept>
<concept>
<code value="G21.8"/>
<display value="Other secondary parkinsonism"/>
</concept>
<concept>
<code value="G21.9"/>
<display value="Secondary parkinsonism, unspecified"/>
</concept>
<concept>
<code value="G23.0"/>
<display value="Hallervorden-Spatz disease"/>
</concept>
<concept>
<code value="G23.1"/>
<display value="Progressive supranuclear ophthalmoplegia"/>
</concept>
<concept>
<code value="G23.2"/>
<display value="Striatonigral degeneration"/>
</concept>
<concept>
<code value="G23.8"/>
<display
value="Other specified degenerative diseases of basal ganglia"/>
</concept>
<concept>
<code value="G23.9"/>
<display value="Degenerative disease of basal ganglia, unspecified"/>
</concept>
<concept>
<code value="G24.09"/>
<display value="Other drug induced dystonia"/>
</concept>
<concept>
<code value="G24.1"/>
<display value="Genomic torsion dystonia"/>
</concept>
<concept>
<code value="G24.2"/>
<display value="Idiopathic nonfamilial dystonia"/>
</concept>
<concept>
<code value="G24.8"/>
<display value="Other dystonia"/>
</concept>
<concept>
<code value="G25.4"/>
<display value="Drug-induced chorea"/>
</concept>
<concept>
<code value="G25.5"/>
<display value="Other chorea"/>
</concept>
<concept>
<code value="G25.70"/>
<display value="Drug induced movement disorder, unspecified"/>
</concept>
<concept>
<code value="G25.71"/>
<display value="Drug induced akathisia"/>
</concept>
<concept>
<code value="G25.79"/>
<display value="Other drug induced movement disorders"/>
</concept>
<concept>
<code value="G25.81"/>
<display value="Restless legs syndrome"/>
</concept>
<concept>
<code value="G25.82"/>
<display value="Stiff-man syndrome"/>
</concept>
<concept>
<code value="G25.83"/>
<display value="Benign shuddering attacks"/>
</concept>
<concept>
<code value="G25.89"/>
<display
value="Other specified extrapyramidal and movement disorders"/>
</concept>
<concept>
<code value="G25.9"/>
<display value="Extrapyramidal and movement disorder, unspecified"/>
</concept>
<concept>
<code value="G26"/>
<display
value="Extrapyramidal and movement disord in diseases classd elswhr"/>
</concept>
<concept>
<code value="G32.0"/>
<display
value="Subac comb degeneration of spinal cord in dis classd elswhr"/>
</concept>
<concept>
<code value="G32.81"/>
<display value="Cerebellar ataxia in diseases classified elsewhere"/>
</concept>
<concept>
<code value="G32.89"/>
<display
value="Oth degeneratv disord of nervous sys in dis classd elswhr"/>
</concept>
<concept>
<code value="G80.3"/>
<display value="Athetoid cerebral palsy"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2022+ HL7 International Clinical Interoperability Council. Package hl7.fhir.us.mcode#2.1.0 based on FHIR 4.0.1. Generated 2023-03-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change